Related Experiment Video
Updated: Aug 27, 2026

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Relationship Between SSRI Exposure During Later Life and Clinical and Neuropathological Correlates of Dementia
Jacob S Shaw1, Michael J C Bray1, Courtney K Harrington2
1Johns Hopkins University School of Medicine (JSS, MJCB, PBR, CGL, MEP), Department of Psychiatry and Behavioral Sciences, Division of Geriatric Psychiatry and Neuropsychiatry, Baltimore, MD.
Objectives:
While depression is a risk factor for dementia, few studies examining the association between selective serotonin reuptake inhibitors (SSRIs) and dementia risk have controlled for confounding major depression and none to our knowledge have examined neuropathological outcomes. We examined the association between continuation of SSRIs in older adults with a lifetime history of depression and progression of cognitive and functional impairment, depression, and neuropathologic correlates of dementia.
Design:
This retrospective cohort study analyzed data from the National Alzheimer's Coordinating Center.
Participants:
Participants aged 55 years or older were required to have clinician documented lifetime history of depression (n = 688). 463 (67.3%) reported continued SSRI use at every study visit prior to death.
Measurements:
Primary clinical outcomes included the Clinical Dementia Rating-Sum of Boxes (CDR-SB), Functional Activities Questionnaire (FAQ), and the 15-item Geriatric Depression Scale (GDS-15). Neuropathological outcomes included assessments of Alzheimer's Disease (AD) pathology and cerebrovascular changes relevant to Vascular dementia (VaD).
Results:
Continued SSRI use during later life was associated with a significantly slower increase on the CDR-SB compared to discontinuation of SSRIs. Rates of change on the FAQ and GDS-15 did not differ significantly between groups. While rates of AD pathology did not differ significantly between groups, continued SSRI use was associated with significantly lower rates of lacunes/infarcts on autopsy after controlling for smoking years and hypertension.
Conclusions:
Persistent use of SSRIs prior to death was associated with decreased progression of cognitive impairment and a nearly 50% reduction of lacunes/infarcts on autopsy. Our study is the first of our knowledge to identify associations between SSRI exposure in later life and neuropathological changes relevant to VaD on autopsy, which is considered the gold standard of diagnosis.
Related Concept Videos
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction
Dementia
The progression of dementia is generally gradual.
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression
